Definitive Contract 75N91022C00027
Award Date
9/20/22
Potential Completion Date
9/19/23
Potential Value
$394K
Federal Agency
National Cancer Institute
Awardee
Pathovacs Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Ames, IA 50011, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
15
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $389,973 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Ai Biosciences, Inc., a small disadvantaged biotechnology company. The contract is for the development of a "Rapid Isothermal Amplification Chip for HPV Detection and Genotyping in Low-Resource Settings." This aligns with NCI's mission to support cancer research and diagnostic technologies,...
This $1,799,981 federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Baebies, Inc., a small business manufacturer of medical diagnostic equipment. The contract is for the development of a point-of-care digital microfluidic platform to diagnose hepatitis C virus (HCV) infection and confirm cure following treatment. This work falls under the Small Business Innovation Research (SBIR) program, which...
This $300,000.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the Department of Health and Human Services' (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Avantgen Inc., a small biotechnology company based in San Diego, California. The contract is for the development of a rapid and point-of-care diagnostic kit for the detection of the hepatitis C virus. This award is part of NIAID's solicitation for...
This is a $382,034 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Phoenix Biosystem, Inc., a self-certified small disadvantaged business. The contract is for the development of HPV point-of-care molecular diagnostics for low- and middle-income countries. The original pre-solicitation announced that NIH and CDC were seeking SBIR proposals to advance their infectious...
<p>This is a $299,961.00 SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cubit Diagnostics, Inc. (doing business as Arete Biosciences) for the development of an ultrasensitive, rapid, and easy-to-use at-home molecular test for Hepatitis C, Hepatitis B, and HIV. The contract has a firm fixed price and a completion date of April 30, 2025. It is designated as a Total Small Business set-aside contract.</p>
This $400,000 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Amplifidx Inc., a woman-owned small business. The contract supports the development of cancer prevention and diagnosis technologies for low-resource settings over a two-year period. This award aligns with NCI's mission to support innovative medical device research and development by small businesses. As a SBIR...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The $299,997.00 contract was awarded to Kephera Diagnostics LLC, a for-profit limited liability company, to develop screening and point-of-care diagnostic assays for the liver fluke infections Opisthorchis viverrini and Clonorchis sinensis. This SBIR contract, which was set...
Qoolabs Inc. has been awarded a $400,000 firm fixed price contract by the Department of Health and Human Services National Institutes of Health National Cancer Institute to develop an at-home rapid test for hepatitis C virus detection. This contract was awarded under the Small Business Innovation Research Program Phase I action, which is set aside for small businesses. Work will be conducted by Qoolabs in San Diego, California through September 2023. The contract responds to a 2020...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Crosslife Technologies Inc., a for-profit small business, for $299,987.00. The contract is for the development of a point of care nucleic acids test for the detection of the liver flukes Opisthorchis viverrini and Clonorchis. This contract is a Definitive Contract with a Firm Fixed Price pricing type. The...
This is a $273,600 firm-fixed-price definitive contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to JBS Science Inc., a small business biotechnology company. The contract is for the development of a cell-free circulating DNA-based assay for liver cancer screening. This award supports NCI's efforts to advance innovative molecular diagnostic technologies for cancer detection and monitoring. As a small business set-aside contract, the...